Valeant Pharmaceuticals's ticker is VRX and the CUSIP is 91911X104. A total of 1 filers reported holding Valeant Pharmaceuticals in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $8,000 | -99.9% | 360 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $5,731,000 | -23.4% | 360 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $7,481,000 | +769.9% | 360 | +500.0% | 0.00% | – |
Q3 2017 | $860,000 | -17.1% | 60 | 0.0% | 0.00% | – |
Q2 2017 | $1,038,000 | +56.8% | 60 | 0.0% | 0.00% | – |
Q1 2017 | $662,000 | -24.0% | 60 | 0.0% | 0.00% | – |
Q4 2016 | $871,000 | -40.9% | 60 | 0.0% | 0.00% | – |
Q3 2016 | $1,473,000 | +21.9% | 60 | 0.0% | 0.00% | – |
Q2 2016 | $1,208,000 | -42.7% | 60 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $2,110,000 | +35066.7% | 60 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $6,000 | -75.0% | 60 | -43.4% | 0.00% | -71.4% |
Q3 2015 | $24,000 | – | 106 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCI Wealth Advisors, Inc. | 25 | $1,000 | 0.00% |
Sonora Investment Management, LLC | 60 | $2,110,000 | 0.00% |